Reply

Hepatology. 2020 Mar;71(3):1132-1133. doi: 10.1002/hep.30999. Epub 2020 Mar 4.

Authors

Yoshitaka Arase^{1

2}, Tatehiro Kagawa¹

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
² Division of Gastroenterology and Hepatology, Tokai University Oiso Hospital, Nakagun, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

Denosumab
Humans
Liver Diseases*
Osteoporosis*

Substances

Denosumab